Cargando…
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a “blind” side effect in a case report
BACKGROUND: We report the first successful treatment of limbal lesions and corneal erosion experienced by a breast cancer patient undergoing trastuzumab treatment. CASE PRESENTATION: A 49-year-old Caucasian woman with early stage breast cancer was treated with adjuvant trastuzumab and subsequently s...
Autores principales: | Orlandi, A., Fasciani, R., Cassano, A., Agresta, A., Calegari, M. A., Caporossi, A., Barone, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682250/ https://www.ncbi.nlm.nih.gov/pubmed/26672594 http://dx.doi.org/10.1186/s12885-015-1969-3 |
Ejemplares similares
-
Methicillin-Resistant Staphylococcus aureus Ocular Infection after Corneal Cross-Linking for Keratoconus: Potential Association with Atopic Dermatitis
por: Fasciani, Romina, et al.
Publicado: (2015) -
Corneal Ulcerations
por: Harry, Philip A.
Publicado: (1908) -
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas
por: Orlandi, A., et al.
Publicado: (2015) -
Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment
por: Sterenczak, Katharina A., et al.
Publicado: (2021) -
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
por: Basso, M, et al.
Publicado: (2013)